SUNDAY 10 OCTOBER 2021
Plenary session 3 Viral infection associated Pulmonary Aspergillosis / Going Viral Going Fungal
09:00
PS3.1 Influenza
09:30
PS3.2 COVID-19
10:00
Coffee break
10:15
Quiz the expert sessions
10:15
Q07 MIC testing in the lab
10:15
Q08 Mucormycosis how to manage
10:15
Q09 TDM
10:15
Q10 Radiology
10:15
Q11 How to use new antifungals in kids
10:15
Q12 Mycological Diagnosis on the bedside: Where are we in 2021
11:00
Poster session 2
12:00
Lunch
12:30
Sponsored Integrated Symposium 4
More information on www.timm2021.org/sponsored-symposia
14:15
Parallel Symposia 14-17
Symposium 14 Fungal respiratory infections in Cystic Fibrosis
14:15
S14.1 Fungal infections in patients with cystic fibrosis
14:35
S14.2 Exophiala dermatitidis in cystic fibrosis
14:55
S14.3 Immunotherapy
Symposium 15 Cryptococosis: From bench to bedside
14:15
S15.1 Advancing prevention and treatment of HIV-associated cryptococcal meningitis
14:35
S15.2 AMBITION trial and beyond
14:55
S15.3 Titan cells in cryptococcosis
15:15
S15.4 Modifications of the cell wall in cryptococcosis
Symposium 16 Azoles, Echinocandins and Polyenes strenghts and weaknesses
14:15
S16.1 Azoles
14:35
S16.2 Echinocandins
14:55
S16.3 Polyenes and biofilms
15:15
S16.4 Breakthrough infections - Definitions, Epidemiology and Outcomes
Symposium 17 Management of immunoallergic fungal diseases
14:15
S17.1 Antifungal treatment in kids with allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization : where do we stand?
14:35
S17.2
14:55
S17.3 Impact of environmental approaches for allergen avoidance and asthma control
15:15
S18.4 Mycology laboratory diagnostic capabilities in different areas of the world
15:45
Coffee break
16:15
Parallel Symposia 18-21
Symposium 18 Diagnosis of invasive aspergillosis: What is new?
16:15
S18.1 Maldi
16:35
S18.2 POC
16:55
S18.3 PCR Diagnosis
Symposium 19 Pre clinical anti fungal studies
16:15
S19.1 Tracking antifungals in the cell
16:35
S19.2 Paradoxical growth
16:55
S19.3 Screens for new compounds
17:15
S19.4 Animal models
Symposium 20 Improving outcomes for patients with invasive fungal infection in routine care in LMIC
16:15
S20.1 From trials to routine care - strengthening pathways to effective implementation – lessons from cryptococcal meningitis and the UNITAID/CHAI programme for advanced HIV disease
16:35
S20.2 CDC Mycology Branch programme to support diagnosis and treatment in LMIC
16:55
S20.3 Improving outcomes for patients with histoplasmosis, mycetoma and chromoblastomycosis in South America
Symposium 21 Invasive fungal infections in special populations
16:15
S21.1 Neonatal candiasis
16:35
S21.2 ECMO and dialysis
16:55
S21.3 Obese patients
18:00
Sponsored Diagnostic Symposium 2
More information on https://www.timm2021.org/sponsored-symposia/
19:30
Congress dinner